Integra Lifesciences Holdings (IART) Retained Earnings (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Retained Earnings data on file, last reported at -$30.9 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 28.35% year-over-year to -$30.9 million; the trailing twelve-month figure through Mar 2026 stood at -$30.9 million (down 28.35% YoY), and the FY2025 full-year result was -$30.1 million, down 103.2% from the prior year.
• Retained Earnings retreated to -$30.9 million in Q1 2026, from -$30.1 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $943.6 million in Q1 2024 to a low of -$32.0 million in Q3 2025.
• A 5-year average of $482.7 million and a median of $731.5 million in 2022 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings soared 12561.69% in 2023 and slumped 103.2% in 2025, its largest moves.
• Tracing IART's Retained Earnings over 5 years: stood at $879.1 million in 2022, then tumbled by 101.72% to -$15.1 million in 2023, then surged by 6322.13% to $939.9 million in 2024, then tumbled by 103.2% to -$30.1 million in 2025, then fell by 2.87% to -$30.9 million in 2026.
• Business Quant data shows IART's Retained Earnings at -$30.9 million in Q1 2026, -$30.1 million in Q4 2025, and -$32.0 million in Q3 2025.